Are you Dr. Wernicke?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
447 W 91st St
Indianapolis, IN 46260Phone+1 319-440-2353- Is this information wrong?
Education & Training
David Geffen School of Medicine at UCLAClass of 1979
Certifications & Licensure
CA State Medical License 1980 - Present
IN State Medical License 1999 - 2025
TX State Medical License 1990 - 2024
Publications & Presentations
PubMed
- 39 citationsSafety and adverse event profile of duloxetine.Joachim F. Wernicke, James Gahimer, Ilker Yalcin, Meghan Wulster-Radcliffe, Lars Viktrup
Expert Opinion on Drug Safety. 2005-10-28 - 37 citationsDetecting treatment emergent adverse events in clinical trials : a comparison of spontaneously reported and solicited collection methods.Joachim F. Wernicke, Douglas E. Faries, Denái R. Milton, Karen Weyrauch
Drug Safety. 2005-01-01 - 32 citationsChanges in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placeb...Joachim F. Wernicke, Lenard A. Adler, T. Thomas Spencer, Scott A. West, Albert J. Allen
Journal of Clinical Psychopharmacology. 2004-02-01
